 | • レポートコード：MRC23Q35838 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、80ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のブール病診断市場について調査・分析し、世界のブール病診断市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（血液検査、アレンテスト、血管造影、組織生検、その他）、用途別セグメント分析（病院、診療所、医学研究センター、学術機関、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、FUJIFILM Holdings、GE Healthcare、Koninklijke Philips、Pluristem Therapeutics、Shimadzu Corporation、Siemens Healthcare GmbH、Stempeutics Research、Canon Medical Systems Corporation、t2cure GmbHなどが含まれています。世界のブール病診断市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ブール病診断市場規模を推定する際に考慮しました。本レポートは、ブール病診断の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ブール病診断に関するビジネス上の意思決定に役立てることを目的としています。 ・ブール病診断市場の概要 - ブール病診断のタイプ別セグメント - 世界のブール病診断市場規模：タイプ別分析（血液検査、アレンテスト、血管造影、組織生検、その他） - ブール病診断の用途別セグメント - 世界のブール病診断市場規模：用途別分析（病院、診療所、医学研究センター、学術機関、その他） - 世界のブール病診断市場規模予測（2018年-2029年） ・ブール病診断市場の成長トレンド - ブール病診断の地域別市場規模（2018年-2029年） - ブール病診断市場ダイナミクス - ブール病診断の業界動向 - ブール病診断市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：血液検査、アレンテスト、血管造影、組織生検、その他 - 世界のブール病診断のタイプ別市場規模（2018年-2023年） - 世界のブール病診断のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、診療所、医学研究センター、学術機関、その他 - 世界のブール病診断の用途別市場規模（2018年-2023年） - 世界のブール病診断の用途別市場規模（2024年-2029年） ・ブール病診断の地域別市場規模 - 北米のブール病診断市場規模（2018年-2029年） - アメリカのブール病診断市場規模（2018年-2029年） - ヨーロッパのブール病診断市場規模（2018年-2029年） - アジア太平洋のブール病診断市場規模（2018年-2029年） - 中国のブール病診断市場規模（2018年-2029年） - 日本のブール病診断市場規模（2018年-2029年） - 韓国のブール病診断市場規模（2018年-2029年） - インドのブール病診断市場規模（2018年-2029年） - オーストラリアのブール病診断市場規模（2018年-2029年） - 中南米のブール病診断市場規模（2018年-2029年） - 中東・アフリカのブール病診断市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 FUJIFILM Holdings、GE Healthcare、Koninklijke Philips、Pluristem Therapeutics、Shimadzu Corporation、Siemens Healthcare GmbH、Stempeutics Research、Canon Medical Systems Corporation、t2cure GmbH ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Bourg Disease Diagnosis market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Bourg Disease Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Bourg Disease Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Bourg Disease Diagnosis in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Bourg Disease Diagnosis include FUJIFILM Holdings, GE Healthcare, Koninklijke Philips, Pluristem Therapeutics, Shimadzu Corporation, Siemens Healthcare GmbH, Stempeutics Research, Canon Medical Systems Corporation and t2cure GmbH, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bourg Disease Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bourg Disease Diagnosis.
The Bourg Disease Diagnosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bourg Disease Diagnosis market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bourg Disease Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
FUJIFILM Holdings
GE Healthcare
Koninklijke Philips
Pluristem Therapeutics
Shimadzu Corporation
Siemens Healthcare GmbH
Stempeutics Research
Canon Medical Systems Corporation
t2cure GmbH
Segment by Type
Blood Test
Allen Test
Angiography
Tissue Biopsy
Other
Segment by Application
Hospital
Clinic
Medical Research Center
Academic Institution
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bourg Disease Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bourg Disease Diagnosis Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Blood Test
1.2.3 Allen Test
1.2.4 Angiography
1.2.5 Tissue Biopsy
1.2.6 Other
1.3 Market by Application
1.3.1 Global Bourg Disease Diagnosis Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Research Center
1.3.5 Academic Institution
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bourg Disease Diagnosis Market Perspective (2018-2029)
2.2 Bourg Disease Diagnosis Growth Trends by Region
2.2.1 Global Bourg Disease Diagnosis Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Bourg Disease Diagnosis Historic Market Size by Region (2018-2023)
2.2.3 Bourg Disease Diagnosis Forecasted Market Size by Region (2024-2029)
2.3 Bourg Disease Diagnosis Market Dynamics
2.3.1 Bourg Disease Diagnosis Industry Trends
2.3.2 Bourg Disease Diagnosis Market Drivers
2.3.3 Bourg Disease Diagnosis Market Challenges
2.3.4 Bourg Disease Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bourg Disease Diagnosis Players by Revenue
3.1.1 Global Top Bourg Disease Diagnosis Players by Revenue (2018-2023)
3.1.2 Global Bourg Disease Diagnosis Revenue Market Share by Players (2018-2023)
3.2 Global Bourg Disease Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bourg Disease Diagnosis Revenue
3.4 Global Bourg Disease Diagnosis Market Concentration Ratio
3.4.1 Global Bourg Disease Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bourg Disease Diagnosis Revenue in 2022
3.5 Bourg Disease Diagnosis Key Players Head office and Area Served
3.6 Key Players Bourg Disease Diagnosis Product Solution and Service
3.7 Date of Enter into Bourg Disease Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bourg Disease Diagnosis Breakdown Data by Type
4.1 Global Bourg Disease Diagnosis Historic Market Size by Type (2018-2023)
4.2 Global Bourg Disease Diagnosis Forecasted Market Size by Type (2024-2029)
5 Bourg Disease Diagnosis Breakdown Data by Application
5.1 Global Bourg Disease Diagnosis Historic Market Size by Application (2018-2023)
5.2 Global Bourg Disease Diagnosis Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Bourg Disease Diagnosis Market Size (2018-2029)
6.2 North America Bourg Disease Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Bourg Disease Diagnosis Market Size by Country (2018-2023)
6.4 North America Bourg Disease Diagnosis Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bourg Disease Diagnosis Market Size (2018-2029)
7.2 Europe Bourg Disease Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Bourg Disease Diagnosis Market Size by Country (2018-2023)
7.4 Europe Bourg Disease Diagnosis Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bourg Disease Diagnosis Market Size (2018-2029)
8.2 Asia-Pacific Bourg Disease Diagnosis Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Bourg Disease Diagnosis Market Size by Region (2018-2023)
8.4 Asia-Pacific Bourg Disease Diagnosis Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bourg Disease Diagnosis Market Size (2018-2029)
9.2 Latin America Bourg Disease Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Bourg Disease Diagnosis Market Size by Country (2018-2023)
9.4 Latin America Bourg Disease Diagnosis Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bourg Disease Diagnosis Market Size (2018-2029)
10.2 Middle East & Africa Bourg Disease Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Bourg Disease Diagnosis Market Size by Country (2018-2023)
10.4 Middle East & Africa Bourg Disease Diagnosis Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 FUJIFILM Holdings
11.1.1 FUJIFILM Holdings Company Detail
11.1.2 FUJIFILM Holdings Business Overview
11.1.3 FUJIFILM Holdings Bourg Disease Diagnosis Introduction
11.1.4 FUJIFILM Holdings Revenue in Bourg Disease Diagnosis Business (2018-2023)
11.1.5 FUJIFILM Holdings Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Detail
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Bourg Disease Diagnosis Introduction
11.2.4 GE Healthcare Revenue in Bourg Disease Diagnosis Business (2018-2023)
11.2.5 GE Healthcare Recent Development
11.3 Koninklijke Philips
11.3.1 Koninklijke Philips Company Detail
11.3.2 Koninklijke Philips Business Overview
11.3.3 Koninklijke Philips Bourg Disease Diagnosis Introduction
11.3.4 Koninklijke Philips Revenue in Bourg Disease Diagnosis Business (2018-2023)
11.3.5 Koninklijke Philips Recent Development
11.4 Pluristem Therapeutics
11.4.1 Pluristem Therapeutics Company Detail
11.4.2 Pluristem Therapeutics Business Overview
11.4.3 Pluristem Therapeutics Bourg Disease Diagnosis Introduction
11.4.4 Pluristem Therapeutics Revenue in Bourg Disease Diagnosis Business (2018-2023)
11.4.5 Pluristem Therapeutics Recent Development
11.5 Shimadzu Corporation
11.5.1 Shimadzu Corporation Company Detail
11.5.2 Shimadzu Corporation Business Overview
11.5.3 Shimadzu Corporation Bourg Disease Diagnosis Introduction
11.5.4 Shimadzu Corporation Revenue in Bourg Disease Diagnosis Business (2018-2023)
11.5.5 Shimadzu Corporation Recent Development
11.6 Siemens Healthcare GmbH
11.6.1 Siemens Healthcare GmbH Company Detail
11.6.2 Siemens Healthcare GmbH Business Overview
11.6.3 Siemens Healthcare GmbH Bourg Disease Diagnosis Introduction
11.6.4 Siemens Healthcare GmbH Revenue in Bourg Disease Diagnosis Business (2018-2023)
11.6.5 Siemens Healthcare GmbH Recent Development
11.7 Stempeutics Research
11.7.1 Stempeutics Research Company Detail
11.7.2 Stempeutics Research Business Overview
11.7.3 Stempeutics Research Bourg Disease Diagnosis Introduction
11.7.4 Stempeutics Research Revenue in Bourg Disease Diagnosis Business (2018-2023)
11.7.5 Stempeutics Research Recent Development
11.8 Canon Medical Systems Corporation
11.8.1 Canon Medical Systems Corporation Company Detail
11.8.2 Canon Medical Systems Corporation Business Overview
11.8.3 Canon Medical Systems Corporation Bourg Disease Diagnosis Introduction
11.8.4 Canon Medical Systems Corporation Revenue in Bourg Disease Diagnosis Business (2018-2023)
11.8.5 Canon Medical Systems Corporation Recent Development
11.9 t2cure GmbH
11.9.1 t2cure GmbH Company Detail
11.9.2 t2cure GmbH Business Overview
11.9.3 t2cure GmbH Bourg Disease Diagnosis Introduction
11.9.4 t2cure GmbH Revenue in Bourg Disease Diagnosis Business (2018-2023)
11.9.5 t2cure GmbH Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details